Metlife IncMET
Price$94.35

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.7B+19.3% YoYTTM through 30 Jun 2026
Net Income $3.6B-18.1% YoYTTM through 30 Jun 2026

Margins

Current
Operating Margin245.0%
Net Margin135.4%

Returns

13.2%ROE
0.5%ROA
42.2%ROIC

Balance Sheet Health

Debt / Equity0.02x
Net Debt-$18.8Bnet cash position
Cash & Equivalents$19.3B

Quality Metrics

Piotroski F-Score5 / 9
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $77.1B
Diluted EPS$5.22TTM
'19'20'21'22'23'24'25
FY2025: $4.71

Dividend

$1.16Per share, FY20261.21%Yield-9.4%5-yr growth

Segment Performance

SegmentRevenueYoYOutlook
Group Benefits
View details

MetLife expects Group Benefits adjusted earnings excluding notable items to grow 7-9% in 2026, with premium, fees, and other revenues growing 4-7%

Retirement and Income Solutions (RIS)
View details

Retirement & Income Solutions adjusted earnings are projected to reach $1.6-$1.8 billion in 2026, with average retained liability exposures growing 3-5%

Asia
View details

The Asia segment is expected to deliver mid-single-digit growth in adjusted earnings in 2026.

Latin America
View details

Latin America is projected to grow adjusted earnings by 6-8% in 2026 and high-single digits thereafter.

EMEA
View details

EMEA's adjusted earnings run rate is expected to be $90-$100 million per quarter in 2026.

MetLife Investment Management (MIM)
View details

Revenues are expected to increase approximately 30% in 2026, with adjusted earnings projected between $240-$280 million, and further growth of 15-20% anticipated in 2027 and 2028.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.